Sort
48,018 grants matching “immunotherapy”
KIR and HLA effects in CNS paraneoplastic syndromes and related neuroimmune conditions
$642,896Emmanuel J Mignot · Stanford University · U01 · FY2022 · NS
Integrating Epigenetic Modulation into DNA Damage Repair
$642,872Pamela N Munster · University Of California, San Francisco · R01 · FY2023 · CA
Defining the role of tumoral MHC Class I Expression in Mediating Colorectal Cancer Racial Disparities
$642,846Mark P Rubinstein · Ohio State University · R01 · FY2023 · CA
HIFU-immunotherapy in pancreatic cancer
$642,831Katherine W Ferrara · Stanford University · R01 · FY2021 · CA
Towards True Precision Oncology: Validation of a Comprehensively Humanized, Autologous Mouse Model
$642,825Ryan C Fields · Washington University · R01 · FY2017 · CA
Strategies for Distinguishing Success in Immunotherapy Treatments (PQ20)
$642,768James R. Heath · California Institute Of Technology · R01 · FY2012 · CA
Targeting complement to enhance antitumor immunity and control malignant effusions in patients with recurrent epithelial ovarian cancer
$642,760Emese Zsiros · Roswell Park Cancer Institute Corp · R01 · FY2025 · CA
Targeting anoctamin 6 to disrupt trogocytosis of cancer-associated fibroblasts
$642,755Igor Astsaturov · Research Inst Of Fox Chase Can Ctr · R01 · FY2025 · CA
Novel endogenous and engineered activators of STING: from mechanisms to cancer therapy
$642,739Xiaochen Bai · Ut Southwestern Medical Center · R01 · FY2025 · CA
Development of Antibody and T-Cell Inducing Vaccines
$642,726Philip O. Livingston · Sloan-Kettering Inst Can Research · P01 · FY2008 · CA
Mechanisms of HBV Functional Cure During Tenofovir-based ART in HIV/HBV Coinfection
$642,704Michael Jeffrey Vinikoor · University Of Alabama At Birmingham · R01 · FY2022 · AI
Developing ultrasound contrast agents and signal processing for structural and functional imaging in type 1 diabetes
$642,688Richard Kp Benninger · University Of Colorado Denver · R01 · FY2025 · DK
Magnetically directed single cell transcriptome analysis in HIV latency
$642,658David Martin Murdoch · Duke University · R56 · FY2014 · AI
Mechanisms of HBV Functional Cure During Tenofovir-based ART in HIV/HBV Coinfection
$642,573Michael Jeffrey Vinikoor · University Of Alabama At Birmingham · R01 · FY2020 · AI
Immune receptor degradation for immune evasion of head and neck cancer
$642,488Dohun Pyeon · Henry Ford Health + Michigan State University Health Sciences · R01 · FY2025 · DE
Engineering T Cell Adoptive Therapy for Glioblastoma
$642,482Gavin Peter Dunn · Massachusetts General Hospital · R01 · FY2025 · NS
Treatment-Related Cardiotoxicity Risk Prediction for Breast Cancer Patients with a Multimodal AI-based System
$642,454Weidan Cao · Ohio State University · R01 · FY2025 · CA
Targeted radiation and immunocytokine therapy for CEA positive malignancies
$642,450John E. Shively · Beckman Research Institute/City Of Hope · R01 · FY2024 · CA
Antigenic determinants of asthma-associated allergens for design of immunotherapy
$642,434Anna Pomes · Indoor Biotechnologies · R01 · FY2020 · AI
Deoxyuridine Contamination and Innate Immune Signaling
$642,394Christopher J. Bakkenist · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · CA
Re-engineering differential regulation of ferroptosis in melanoma microenvironment
$642,352Yuri Bunimovich · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · CA
Re-engineering differential regulation of ferroptosis in melanoma microenvironment
$642,352Yuri Bunimovich · University Of Pittsburgh At Pittsburgh · R01 · FY2024 · CA
Project 3: Tools for Capturing Immune Cell/Cancer Cell Interactions in Cancer Immunotherapies and Combination Immunotherapies
$642,335James R. Heath · California Institute Of Technology · U54 · FY2016 · CA
Naive T cells in Cancer Immune Evasion and Immunotherapy
$642,318Weiping Zou · University Of Michigan At Ann Arbor · R01 · FY2020 · CA
Remodeling Chromatin and the Tumor Microenvironment: Direct Oncogenesis and Therapeutic Targeting
$642,266David E Fisher · Massachusetts General Hospital · P01 · FY2025 · CA